Nucleocapsid-specific antibody function is associated with therapeutic benefit from Covid-19 Convalescent plasma therapy. Herman et al.
Published: 11 October 2022| Version 1 | DOI: 10.17632/zc5dzbn9tb.1
Contributor:
Jonathan HermanDescription
Processed Data for "Nucleocapsid-specific antibody function is associated with therapeutic benefit from Covid-19 Convalescent plasma therapy" Herman et al. Sheet 1 has the log transformed mean antibody titer and FcR-binding as well as mean functional antibody features data. Sheet 2 has the Spike-specific antibody Fc-glycan data.
Files
Institutions
Brigham and Women's Hospital, Ragon Institute, Massachusetts General Hospital
Categories
Immunology, Antibody, Immunity, COVID-19